Minirin Melt (Desmopressin)

Desmopressin, the active ingredient in Minirin Melt, is a vasopressin analog presented as a sublingual melt tablet for sublingual use. It selectively stimulates renal V2 receptors to reduce urine output, making it useful in central diabetes insipidus, nocturnal enuresis in children, and as an adjunct to control bleeding in hemophilia A patients.

GNH USA supplies Minirin Melt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory conformity across markets and providing reliable logistics support.

Desmopressin acts on the antidiuretic hormone pathway to manage disorders of water balance and coagulation. - Central diabetes insipidus: reduces excessive urine production and helps maintain fluid balance by enhancing water reabsorption in the kidneys. - Nocturnal enuresis: decreases nighttime urine output, improving sleep continuity and reducing bedwetting episodes in children and adolescents. - Hemophilia A: raises plasma levels of factor VIII and von Willebrand factor, supporting hemostasis during minor surgical procedures or bleeding episodes.

Desmopressin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild to moderate intensity. - Nausea: occasional upset stomach. - Mild hyponatremia: slight reduction in blood sodium without severe symptoms.

Serious or Rare Side Effects: - Severe hyponatremia: can cause seizures, confusion, or coma. - Water intoxication: excessive fluid retention leading to cerebral edema. - Allergic reactions: rash, urticaria, or anaphylaxis.

Before prescribing Desmopressin, clinicians should consider several safety considerations to minimize risks. - Assess fluid balance: evaluate patient’s hydration status and limit excessive fluid intake. - Monitor electrolytes: check serum sodium regularly, especially in the elderly or those on diuretics. - Caution in renal impairment: adjust use and monitor kidney function closely. - Avoid in uncontrolled hypertension: watch blood pressure as water retention may exacerbate. - Contraindicated in known hypersensitivity: discontinue if allergic reaction occurs. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture.

Desmopressin can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Concomitant use with other antidiuretic agents (e.g., carbamazepine, chlorpropamide) may precipitate severe hyponatremia. - NSAIDs (e.g., ibuprofen, naproxen) can reduce renal prostaglandin synthesis, increasing risk of water retention. - Strong CYP2C9 inhibitors (e.g., fluconazole) may affect desmopressin metabolism, though limited.

Moderate Interactions (Monitor Closely): - Diuretics (especially thiazides): enhance sodium loss, requiring closer electrolyte monitoring. - Anticoagulants (e.g., warfarin): desmopressin may affect bleeding time; monitor coagulation parameters. - Opioids (e.g., morphine): may potentiate antidiuretic effect, watch fluid balance.